physostigmine has been researched along with Amentia in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (78.95) | 18.7374 |
| 1990's | 4 (10.53) | 18.2507 |
| 2000's | 4 (10.53) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigg, D; Briley, M; Calmel, F; Carilla, E; Chopin, P; Stenger, A; Vidaluc, JL | 1 |
| Arya, P; Butler, R; Warner, J | 2 |
| Araujo, JA; Milgram, NW; Studzinski, CM | 1 |
| Butler, R; Warner, J; Wuntakal, B | 1 |
| Jolles, J; Verhoeven, WM | 1 |
| Davies, P | 1 |
| Davis, KL; Greenwald, BS | 1 |
| Spar, JE | 1 |
| Fuld, PA; Masur, DM; Sharpless, NS; Thal, LJ | 1 |
| Davis, KL; Mohs, RC | 2 |
| Blass, JP; Weksler, ME | 1 |
| Wettstein, A | 1 |
| Albanese, A; Caltagirone, C; Gainotti, G; Masullo, C | 1 |
| Raber, P | 1 |
| Christie, JE; Ferguson, J; Glen, AI; Shering, A | 1 |
| Denber, HC | 1 |
| Caltagirone, C; Gainotti, G; Masullo, C | 1 |
| Ashford, JW; Cochran, L; Jarvik, LF; Schaeffer, J; Soldinger, S | 1 |
| Corkin, S; Growdon, JH | 1 |
| Drachman, DA; Sahakian, BJ | 1 |
| Davis, BM; Davis, KL; Horvath, TB; Levy, MI; Mohs, RC; Rosenberg, GS; Tinklenberg, JR | 1 |
| Aigner, TG; Matsuoka, N | 1 |
| Kurz, A | 1 |
| Smith, CM; Swash, M | 2 |
| Davis, KL; Yamamura, HI | 1 |
| Muramoto, O; Sugishita, M; Sugita, H; Toyokura, Y | 1 |
| Levin, HS; Peters, BH | 1 |
| Maeda, N; Matsuoka, N; Ohkubo, Y; Yamaguchi, I; Yamazaki, M | 1 |
| Haigh, JR; Lines, CR; Poppleton, P; Preston, GC; Traub, M; Ward, C | 1 |
| Genovese, N; Klawans, HL | 1 |
| Ohtomo, E | 1 |
| Adem, A; Hardy, J; Nilsson, L; Nordberg, A; Winblad, B | 1 |
11 review(s) available for physostigmine and Amentia
| Article | Year |
|---|---|
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
Topics: Acetylcholine; Aging; Animals; Cognition Disorders; Dementia; Disease Models, Animal; Dogs; Humans; Physostigmine; Scopolamine | 2005 |
Dementia.
Topics: Alzheimer Disease; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine | 2004 |
Dementia.
Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine | 2005 |
[Psychopharmacologic treatment of cognitive function disorders in aging persons: current possibilities].
Topics: Adrenocorticotropic Hormone; Aged; Alzheimer Disease; Anticonvulsants; Brain; Catecholamines; Choline; Dementia; Dihydroergotoxine; Humans; Memory Disorders; Narcotic Antagonists; Nerve Tissue Proteins; Neuropsychology; Parasympatholytics; Phosphatidylcholines; Physostigmine; Piracetam; Trace Elements; Vasopressins; Vitamins | 1984 |
An update on the neurochemistry of Alzheimer disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Arecoline; Brain; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Dementia; Dopamine; gamma-Aminobutyric Acid; Humans; Neurotransmitter Agents; Norepinephrine; Peptides; Phosphatidylcholines; Physostigmine; Serotonin | 1983 |
Experimental pharmacology of Alzheimer disease.
Topics: Acetylcholine; Adult; Aged; Alzheimer Disease; Dementia; Dopamine; gamma-Aminobutyric Acid; Humans; Middle Aged; Norepinephrine; Oxotremorine; Peptides; Physostigmine; Receptors, Cholinergic; Serotonin; Somatostatin; Synaptic Transmission | 1983 |
[Effect pf anti-dementia drugs on the daily routine and attitude of dementia patients].
Topics: Activities of Daily Living; Aged; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia; Humans; Muscarinic Agonists; Neuropsychological Tests; Nootropic Agents; Physostigmine; Sick Role; Treatment Outcome | 1999 |
Cholinergic underactivity in human memory disorders.
Topics: Aging; Brain Chemistry; Dementia; Humans; Memory Disorders; Parasympathetic Nervous System; Physostigmine; Receptors, Muscarinic | 1978 |
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
[Recent drug therapy of senile dementia].
Topics: Adrenocorticotropic Hormone; Alzheimer Disease; Choline; Dementia; Dihydroergotoxine; Humans; Narcotic Antagonists; Peptide Fragments; Phosphatidylcholines; Physostigmine; Piracetam; Pyrrolidines; Succinimides | 1987 |
9 trial(s) available for physostigmine and Amentia
| Article | Year |
|---|---|
Memory enhancement with oral physostigmine in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Phosphatidylcholines; Physostigmine | 1983 |
Oral physostigmine and lecithin improve memory in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Double-Blind Method; Drug Therapy, Combination; Humans; Memory Disorders; Middle Aged; Phosphatidylcholines; Physostigmine | 1983 |
A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Physostigmine; Psychological Tests | 1982 |
Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Memory; Memory Disorders; Middle Aged; Physostigmine; Random Allocation | 1982 |
Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia.
Topics: Alzheimer Disease; Arecoline; Clinical Trials as Topic; Dementia; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Memory; Middle Aged; Physostigmine | 1981 |
Physostigmine in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Clinical Trials as Topic; Dementia; Drug Evaluation; Humans; Injections, Subcutaneous; Intelligence Tests; Male; Memory; Memory Disorders; Neuropsychological Tests; Physostigmine; Placebos; Research Design | 1979 |
Effect of physostigmine on constructional and memory tasks in Alzheimer's disease.
Topics: Alzheimer Disease; Dementia; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Physostigmine; Receptors, Cholinergic | 1979 |
Effects of physostigmine and lecithin on memory in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Dementia; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Phosphatidylcholines; Physostigmine | 1979 |
Pharmacology of dementia.
Topics: 4-Aminopyridine; Acetylcholine; Adenosine Triphosphate; Aged; Aminopyridines; Central Nervous System Stimulants; Cerebrovascular Circulation; Clinical Trials as Topic; Dementia; Double-Blind Method; Humans; Levodopa; Nafronyl; Narcotic Antagonists; Nerve Tissue Proteins; Parasympathomimetics; Pentylenetetrazole; Physostigmine; Piracetam; Procainamide; Vasodilator Agents; Vasopressins | 1986 |
19 other study(ies) available for physostigmine and Amentia
| Article | Year |
|---|---|
Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity.
Topics: Acetylcholinesterase; Amnesia; Animals; Avoidance Learning; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Hydrogen Bonding; Mice; Molecular Conformation; Molecular Structure; Piperidines; Rats; Scopolamine; Structure-Activity Relationship; Thiourea | 1994 |
Dementia in the aged.
Topics: Aged; Cerebral Infarction; Choline; Creutzfeldt-Jakob Syndrome; Dementia; Depressive Disorder; Diagnosis, Differential; Humans; Huntington Disease; Phosphatidylcholines; Physostigmine; Psychoses, Substance-Induced | 1982 |
Toward an effective treatment of Alzheimer's disease.
Topics: Administration, Oral; Alzheimer Disease; Cognition; Dementia; Female; Humans; Male; Physostigmine | 1983 |
No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Humans; Male; Memory; Middle Aged; Phosphatidylcholines; Physostigmine; Verbal Learning | 1983 |
Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia.
Topics: Alzheimer Disease; Cholinesterases; Dementia; Humans; Memory; Physostigmine | 1983 |
The dementia dilemma: help is out there.
Topics: Aged; Alzheimer Disease; Ambulatory Care Facilities; Benzyl Alcohols; Dementia; Drug Combinations; Health Services for the Aged; Humans; Naloxone; Physician's Role; Physostigmine; Washington | 1983 |
Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Dementia; Female; Humans; Male; Middle Aged; Naloxone; Physostigmine | 1983 |
Physostigmine in the treatment of memory disorders: a case report.
Topics: Alzheimer Disease; Amnesia; Dementia; Humans; Male; Middle Aged; Physostigmine | 1982 |
Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia.
Topics: Alzheimer Disease; Arousal; Cognition; Dementia; Humans; Memory; Mental Recall; Middle Aged; Physostigmine; Psychological Tests | 1982 |
Physostigmine and its effect on six patients with dementia.
Topics: Aged; Alzheimer Disease; Dementia; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Memory; Middle Aged; Physostigmine | 1981 |
Neurochemical approaches to the treatment of senile dementia.
Topics: Acetylcholine; Aged; Alzheimer Disease; Animals; Choline; Choline O-Acetyltransferase; Dementia; Dyskinesia, Drug-Induced; Female; Humans; Learning; Male; Memory; Middle Aged; Phosphatidylcholines; Physostigmine; Rats; Receptors, Cholinergic | 1980 |
Memory and cognitive function in the elderly. A preliminary trial of physostigmine.
Topics: Aged; Aging; Cognition; Dementia; Humans; Memory; Middle Aged; Physostigmine; Wechsler Scales | 1980 |
Human memory and the effects of physostigmine and choline chloride [proceedings].
Topics: Adolescent; Adult; Aged; Choline; Dementia; Double-Blind Method; Humans; Memory; Middle Aged; Physostigmine | 1980 |
FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine.
Topics: Animals; Benzamides; Cholinesterase Inhibitors; Dementia; Dizocilpine Maleate; Dose-Response Relationship, Drug; Macaca mulatta; Muscarinic Antagonists; Nootropic Agents; Physostigmine; Piperazines; Receptors, N-Methyl-D-Aspartate; Scopolamine; Visual Perception | 1997 |
Drug combination may improve memory.
Topics: Alzheimer Disease; Dementia; Drug Therapy, Combination; Humans; Phosphatidylcholines; Physostigmine | 1979 |
Possible biochemical basis of memory disorder in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Dementia; Humans; Male; Memory; Memory Disorders; Physostigmine | 1979 |
Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks.
Topics: Aging; Animals; Avoidance Learning; Brain; Choline O-Acetyltransferase; Cognition Disorders; Dementia; Discrimination Learning; Disease Models, Animal; Male; Memory Disorders; Methamphetamine; Motor Activity; Physostigmine; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Scopolamine; Sulfonamides | 1992 |
Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.
Topics: Acoustic Stimulation; Adult; Anti-Anxiety Agents; Attention; Cognition Disorders; Dementia; Disease Models, Animal; Female; Flumazenil; Humans; Male; Memory Disorders; Photic Stimulation; Physostigmine; Psychomotor Performance; Pupil; Reaction Time; Scopolamine | 1989 |
Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?
Topics: Acetylcholine; Aged; Alzheimer Disease; Aminoacridines; Dementia; Female; Frontal Lobe; Humans; In Vitro Techniques; Male; Physostigmine; Receptors, Nicotinic; Tacrine | 1987 |